- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Growth hormone (Norditropin, Novo nordisk)
Total 1329 results
-
Millennium Pharmaceuticals, Inc.Completed
-
PETHEMA FoundationMillennium Pharmaceuticals, Inc.; CelgeneCompleted
-
NYU Langone HealthCelgeneTerminatedMultiple MyelomaUnited States
-
University of ArkansasCompleted
-
Hospital Universitari Vall d'Hebron Research InstituteCompleted
-
Hellenic Society of HematologyGlaxoSmithKlineRecruitingNeoplasms | Multiple Myeloma | Paraproteinemias | Blood Protein Disorders | Corneal Disease | Gammopathy, Monoclonal | Haematologic Disease | Neoplasm, Plasma CellGreece
-
Tel-Aviv Sourasky Medical CenterRecruitingRefractory Multiple Myeloma | Multiple Myeloma in RelapseIsrael
-
University Hospital, ToulouseRecruiting
-
National Cancer Institute (NCI)RecruitingLymphoma | Diffuse Large B-Cell Lymphoma | Burkitt Lymphoma | Non-Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingPrimary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS) | Aggressive B-cell Lymphoma With Secondary Involvement of the CNSUnited States
-
TakedaActive, not recruiting
-
Dana-Farber Cancer InstituteTakeda; CelgeneActive, not recruitingSmoldering Multiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, France, Korea, Republic of, Canada, Belgium, New Zealand, Russian Federation
-
Emory UniversityMerck Sharp & Dohme LLC; Celgene CorporationCompleted
-
Dana-Farber Cancer InstituteNovartisCompletedMultiple Myeloma in RelapseUnited States
-
Bristol-Myers SquibbCompleted
-
Merck Sharp & Dohme LLCTerminated
-
University Hospital, ToulouseTakeda; CelgeneTerminated
-
CelgeneMultiple Myeloma Research ConsortiumCompleted
-
Weill Medical College of Cornell UniversityPfizer; Celgene CorporationTerminatedMultiple MyelomaUnited States
-
Fondazione EMN Italy OnlusCompleted
-
National University Hospital, SingaporeJanssen, LP; International Myeloma FoundationUnknownRelapse and / or Refractory MyelomaSingapore, Hong Kong, Taiwan, Korea, Republic of
-
PETHEMA FoundationCompletedPrimary Systemic AmyloidosisSpain
-
King's College Hospital NHS TrustCompleted
-
Massachusetts Eye and Ear InfirmaryWithdrawnChoroidal Neovascularization | Myopia | Angioid Streaks | Multifocal Choroiditis | Punctate Inner Choroidopathy (PIC) | Ocular Histoplasmosis Syndrome | Central Serous Chorioretinopathy (CSC) | Trauma, or Hereditary Eye Diseases
-
Gruppo Italiano Studio LinfomiCompleted
-
University of ArkansasWithdrawnMultiple MyelomaUnited States
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaGermany, Korea, Republic of, Italy, France, Japan, Israel, Belgium, Denmark, Sweden, China, Spain, Czechia, Poland, Australia, Netherlands, Argentina, Canada, United Kingdom, Greece, Brazil, India
-
PfizerRecruitingMultiple MyelomaChina, Korea, Republic of, Taiwan, United States, France, Sweden, Australia, Japan, Spain, Czechia, United Kingdom, Canada, Germany, New Zealand, Italy, Poland, Netherlands, Austria, Mexico, Finland, Argentina, Belgium, Brazil, Greece, ... and more
-
Peking Union Medical College HospitalThe First Affiliated Hospital of Anhui Medical University; Peking University... and other collaboratorsRecruiting
-
CellCentric Ltd.RecruitingAcute Myeloid Leukemia | Multiple Myeloma | Non Hodgkin Lymphoma | Peripheral T Cell Lymphoma | Haematological Malignancy | Higher-risk Myelodysplastic SyndromeUnited Kingdom, United States, France, Sweden, Spain
-
Larysa SanchezJanssen, LPRecruitingNewly Diagnosed Multiple MyelomaUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); AmgenActive, not recruitingPlasma Cell MyelomaUnited States
-
Hackensack Meridian HealthJanssen, LPTerminatedMultiple MyelomaUnited States
-
Paul Richardson, MDM.D. Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Massachusetts... and other collaboratorsActive, not recruiting
-
NCIC Clinical Trials GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada
-
Nantes University HospitalCompleted
-
CelgeneCompletedMultiple MyelomaUnited States, Spain, United Kingdom, Italy, Israel, Portugal, Germany, Turkey, Greece, Ireland, Austria, Norway, Netherlands, Denmark, Poland, France, Russian Federation, Canada, Finland, Japan, Puerto Rico, Sweden
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed and/or Refractory Multiple MyelomaUnited States, France, Norway, Spain, Israel, United Kingdom, Italy, Australia, Germany, Greece, Canada, Czechia, Turkey, Russian Federation, Denmark, Sweden, Belgium, Netherlands
-
PETHEMA FoundationCelgene Corporation; AmgenActive, not recruitingSmoldering Multiple MyelomaSpain
-
University of Maryland, BaltimoreNational Cancer Institute (NCI); University of Maryland Greenebaum Cancer CenterCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
University Hospital, LimogesMinistry of Health, France; Celgene CorporationCompleted
-
Columbia UniversityGenentech, Inc.TerminatedProstate CancerUnited States
-
CelgeneCompletedProstate CancerUnited States, Spain, France, Belgium, Australia, Denmark, Austria, United Kingdom, Netherlands, Poland, Israel, Italy, Germany, Greece, Canada, Czechia, Hungary, Mexico, Russian Federation, South Africa, Sweden
-
King Saud UniversityUnknownDiabetic Macular EdemaSaudi Arabia
-
Nantes University HospitalCompleted
-
University of California, San DiegoUniversity of VirginiaCompleted
-
Stanford UniversityWithdrawnProstate Cancer | Castrate Resistant Prostate Cancer
-
The University of Texas Medical Branch, GalvestonCompletedTraumatic Brain InjuryUnited States
-
University of California, San FranciscoNational Cancer Institute (NCI); Memorial Sloan Kettering Cancer CenterCompleted